STOCK TITAN

Accuray Ownership: Neuberger Berman Files Amended 13G at 4.7%

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Accuray Inc. (ARAY) has received an amended Schedule 13G filing (Amendment No. 5) from Neuberger Berman Group LLC and Neuberger Berman Investment Advisers LLC. As of 07/31/2025 the Neuberger entities beneficially own 5,242,373 common shares, equal to 4.65 % of Accuray’s outstanding stock. The institutions report shared voting power over 3,991,789 shares and shared dispositive power over the full 5,242,373 shares; they hold no sole voting or dispositive authority. Because the position now falls below the 5 % threshold, Item 5 (“ownership of 5 % or less”) is checked. The filing is made under Rule 13d-1(b), classifying the filers as a parent holding company (HC) and an investment adviser (IA). The signatory, Managing Director Brad Cetron, certifies that the shares were acquired in the ordinary course of business and not to influence control of Accuray.

Positive

  • Institutional support: Neuberger Berman still holds 4.65 % of ARAY, signalling continued, if reduced, confidence.

Negative

  • Stake below 5 %: Position drop below the Schedule 13D/G reporting threshold may imply recent share sales or dilution.

Insights

TL;DR – Neutral: institutional holder discloses 4.65 % stake, below 5 % reporting line.

The amended 13G shows Neuberger Berman’s aggregate position at 5.24 million shares, worth roughly US$(market-value depends on price). Falling under 5 % suggests recent selling or share-count dilution, but the group remains a meaningful institutional owner with almost 4.7 % of the float and retains full shared dispositive authority. The ordinary-course certification indicates no activist intent. From a valuation perspective, the disclosure neither strengthens nor weakens Accuray’s fundamentals; it simply updates ownership transparency.

TL;DR – Governance impact minimal; no control intent declared.

The filing satisfies Exchange Act obligations after Neuberger’s stake slipped beneath the 5 % threshold. Because the entities disclaim beneficial ownership and certify non-control intent, board or strategic influence is unlikely. Investors should monitor future amendments for activist escalation, but current disclosure is routine and not impactful to governance dynamics.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Neuberger Berman Group LLC
Signature:Brad Cetron
Name/Title:Brad Cetron - Managing Director
Date:08/05/2025
Neuberger Berman Investment Advisers LLC
Signature:Brad Cetron
Name/Title:Brad Cetron - Managing Director
Date:08/05/2025

FAQ

How many Accuray (ARAY) shares does Neuberger Berman own?

The amended 13G reports 5,242,373 common shares beneficially owned.

What percentage of Accuray’s outstanding stock does this represent?

The filing states 4.65 % of the common shares outstanding.

Does Neuberger Berman have sole voting power over any ARAY shares?

No. Sole voting power is 0; all voting authority is shared on 3,991,789 shares.

Why was the Schedule 13G/A filed?

Rule 13d-1(b) requires institutional investors to update ownership; the stake now sits below 5 %.

Who signed the filing on behalf of Neuberger Berman?

Managing Director Brad Cetron signed on 08/05/2025.

Is Neuberger Berman seeking control of Accuray?

No. The certification states the shares were acquired in the ordinary course and not to change or influence control.
Accuray Incorp

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Latest SEC Filings

ARAY Stock Data

97.44M
108.43M
2.06%
71.26%
1.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MADISON